Modulating Poly(ether Sulfone) Ultrafiltration Membrane Microstructure via Coagulation Bath Engineering for Enhanced Antifouling Performance
Langmuir · 03.11.2026 · 42 (43) · 31952-31964
DOI: 10.1021/acs.langmuir.6c04355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, online erschienen am 19.10.2026. Verfasst von Ping Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Materials Science, Sichuan Normal University, Chengdu, Sichuan610068, China. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
The coagulation bath plays a decisive role in determining membrane morphology and separation performance during the nonsolvent induced phase separation (NIPS) process. In this study, poly(ether sulfone) (PES) ultrafiltration membranes were fabricated using different coagulation media, including water, ethanol, saturated NaCl solution, and a hydrogel system, to investigate the relationship among phase inversion behavior, membrane morphology, and antifouling performance. The thermodynamic stability and phase separation kinetics of the casting system were analyzed through cloud-point measurements. The membrane morphology, pore structure, wettability, separation performance, and antifouling performance were systematically characterized. The results demonstrated that the coagulation medium significantly influenced the phase inversion pathway and membrane morphology. Rapid demixing in water produced membranes with relatively large pores and low porosity, whereas the hydrogel coagulation bath markedly retarded solvent–nonsolvent exchange, promoting the formation of a dense, uniform sponge-like structure with the highest porosity and the smallest average pore size. The membrane prepared via hydrogel-induced phase separation, designated as P-AG (coagulation bath: agarose hydrogel), exhibited a pure water flux of 73.3 L·m–2 h–1 and a water contact angle (WCA) of 58.75°. It showed the flux recovery ratio (FRR) values of 89.27% and 96.01% for bovine serum albumin (BSA) filtration and emulsion filtration, respectively, and had the lowest irreversible fouling resistance (Rir). Cyclic filtration tests further confirmed its excellent fouling reversibility and long-term operational stability. This work demonstrates that hydrogel-assisted phase inversion provides an effective strategy for tailoring membrane pore architecture. The proposed coagulation bath engineering approach offers new opportunities for developing antifouling membranes toward oily wastewater treatment.
Autor:innen und Institutionen
- College of Chemistry and Materials Science, Sichuan Normal University, Chengdu, Sichuan610068, China.
- Sichuan Environmental Protection Key Laboratory of Persistent Pollutant Wastewater Treatment, Sichuan Provincial Engineering Research Center of Livestock Manure Treatment and Recycling, Sichuan Normal University, Chengd…
ORCID-Profile: Xiaobo Gong, Meng Zhu
Förderung
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhang, P., Xie, A., Wang, Y., Gong, X., & Zhu, M. (2026). Modulating Poly(ether Sulfone) Ultrafiltration Membrane Microstructure via Coagulation Bath Engineering for Enhanced Antifouling Performance. Langmuir, 42(43), 31952-31964. https://doi.org/10.1021/acs.langmuir.6c04355
Vancouver
Zhang P, Xie A, Wang Y, Gong X, Zhu M. Modulating Poly(ether Sulfone) Ultrafiltration Membrane Microstructure via Coagulation Bath Engineering for Enhanced Antifouling Performance. Langmuir. 2026;42(43):31952-31964. doi:10.1021/acs.langmuir.6c04355
BibTeX
@article{Zhang2026,
author = {Zhang, Ping and Xie, Ailin and Wang, Ying and Gong, Xiaobo and Zhu, Meng},
title = {Modulating Poly(ether Sulfone) Ultrafiltration Membrane Microstructure via Coagulation Bath Engineering for Enhanced Antifouling Performance},
journal = {Langmuir},
year = {2026},
volume = {42},
number = {43},
pages = {31952--31964},
doi = {10.1021/acs.langmuir.6c04355}
}
EUVIMED